Department of Psychiatry, Federico II University, Naples, Italy; Polyedra Research Foundation, Teramo, Italy.
The University of Buenos Aires, School of Medicine, Institute of Pharmacology, Argentina.
J Affect Disord. 2021 Feb 1;280(Pt A):409-431. doi: 10.1016/j.jad.2020.11.015. Epub 2020 Nov 13.
There are scarce and discrepant data about the prevalence and correlates of co-occurring eating disorders (EDs) among people with a primary diagnosis of bipolar disorder (BD), and vice-versa, compelling a systematic review and meta-analysis on the matter.
MEDLINE/PsycINFO databases were systematically searched for original studies documenting BD⇌ED comorbidity across the lifespan, from inception up until April 20, 2020. Random-effects meta-analysis and meta-regression analyses were conducted, accounting for multiple moderators.
Thirty-six studies involved 15,084 primary BD patients. Eleven studies encompassed 15,146 people with primary EDs. Binge eating disorder (BED) occurred in 12.5% (95%C.I.=9.4-16.6%, I=93.48%) of BDs, while 9.1% (95%C.I.=3.3-22.6%) of BEDs endorsed BD. Bulimia Nervosa (BN) occurred in 7.4% (95%C.I.=6-10%) of people with BD, whereas 6.7% (95%C.I.=12-29.2%) of subjects with BN had a diagnosis of BD. Anorexia Nervosa (AN) occurred in 3.8% (95%C.I.=2-6%) of people with BDs; 2% (95%C.I.=1-2%) of BD patients had a diagnosis of AN. Overall, BD patients with EDs had higher odds of being female vs. non-ED controls. Several moderators yielded statistically significant differences both within- and between different types of BDs and EDs.
Scant longitudinal studies, especially across different EDs and pediatric samples. High heterogeneity despite subgroup comparisons. Limited discrimination of the quality of the evidence.
The rates of BD⇌ED comorbidity vary across different diagnostic groups, more than they do according to the "direction" of BD⇌ED. Further primary studies should focus on the risks, chronology, clinical impact, and management of the onset of intertwined BD⇌ED across different ages, promoting a continuum approach.
关于双相障碍(BD)患者和原发性进食障碍(ED)患者共病的患病率和相关因素的数据稀缺且存在差异,反之亦然,因此有必要对此进行系统综述和荟萃分析。
系统检索了 MEDLINE/PsycINFO 数据库中从建库至 2020 年 4 月 20 日记录 BD 与 ED 共病的原始研究,涵盖了整个生命周期。采用随机效应荟萃分析和荟萃回归分析,并考虑了多个调节变量。
36 项研究纳入了 15084 例原发性 BD 患者,11 项研究纳入了 15146 例原发性 ED 患者。BD 患者中暴食障碍(BED)的发生率为 12.5%(95%CI=9.4-16.6%,I=93.48%),而 BED 患者中 BD 的发生率为 9.1%(95%CI=3.3-22.6%)。BD 患者中神经性贪食症(BN)的发生率为 7.4%(95%CI=6-10%),而 BN 患者中 BD 的发生率为 6.7%(95%CI=12-29.2%)。BD 患者中神经性厌食症(AN)的发生率为 3.8%(95%CI=2-6%),而 AN 患者中 BD 的发生率为 2%(95%CI=1-2%)。总体而言,BD 患者中 ED 患者女性的可能性高于非 ED 对照组。多个调节变量在不同类型的 BD 和 ED 内和之间都产生了具有统计学意义的差异。
纵向研究较少,特别是针对不同 ED 和儿科样本。尽管进行了亚组比较,但异质性仍然很高。对证据质量的区分有限。
BD-ED 共病的发生率在不同的诊断组之间存在差异,而不是根据 BD-ED 的“方向”存在差异。进一步的初步研究应关注不同年龄段 BD-ED 相互交织的发病风险、病程、临床影响和管理,促进连续性方法。